FDA.reportPublic FDA data

Application 215425

Type
NDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EPINEPHRINEEPINEPHRINESOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS30MG/30ML (1MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81608ORIG 2025-03-17
81597ORIG 2025-03-17